TipRanks on MSN
CVS Health price target raised to $101 from $93 at JPMorgan
JPMorgan raised the firm’s price target on CVS Health (CVS) to $101 from $93 and keeps an Overweight rating on the shares.
CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...
CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein ...
Discover why CVS Health Corporation is a top S&P 500 performer in 2025. See bullish forecasts, strong growth, and a new price ...
WEST ST. PAUL, Minn. – West St. Paul Police are looking for a suspect in the robbery of both a CVS Pharmacy and Target store pharmacy. Friday at 6:15 p.m. West St. Paul Police Department responded to ...
Headquartered in Woonsocket, Rhode Island, CVS Health Corporation (CVS), with a market cap of $82 billion, provides health solutions in the United States. The company operates through Health Care ...
Members of Congress have traded $CVS stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales. Here’s a breakdown of recent ...
CVS Health raised its 2025 profit forecast today, signaling steady progress in the health conglomerate’s turnaround plan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results